Pub Date : 2025-01-01DOI: 10.1016/j.rccl.2024.04.001
Diana Isabel Katekaru-Tokeshi , Félix Alonso Revilla-Manchego , Luz Marilyn Vásquez-Salazar , Moisés Jiménez-Santos
{"title":"Leiomiomatosis intravenosa con extensión intracardiaca y a la arteria pulmonar","authors":"Diana Isabel Katekaru-Tokeshi , Félix Alonso Revilla-Manchego , Luz Marilyn Vásquez-Salazar , Moisés Jiménez-Santos","doi":"10.1016/j.rccl.2024.04.001","DOIUrl":"10.1016/j.rccl.2024.04.001","url":null,"abstract":"","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 65-66"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140784902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.rccl.2024.07.006
Danilo Weir-Restrepo , María Antonia Mesa-Maya , María Isabel Carvajal-Vélez , Pedro Abad-Díaz , Laura Duque-González
The quadricuspid aortic valve (QAV) is a rare congenital heart defect characterized by the presence of 4 cusps in the aortic valve structure. It is frequently associated with other congenital heart defects. Patients are usually asymptomatic, but when this condition is associated with functional disorders such as aortic regurgitation or stenosis, clinical manifestations are evident. The final diagnosis is made using different cardiac imaging techniques such as echocardiography, cardiac tomography, and nuclear magnetic resonance.
The treatment of this condition depends on the functionality of the aortic valve, and accordingly will be the indication for surgical treatment. The prognosis is generally favorable and depends on the functional compromise of the valve.
{"title":"Válvula aórtica cuadricúspide: una revisión de la literatura","authors":"Danilo Weir-Restrepo , María Antonia Mesa-Maya , María Isabel Carvajal-Vélez , Pedro Abad-Díaz , Laura Duque-González","doi":"10.1016/j.rccl.2024.07.006","DOIUrl":"10.1016/j.rccl.2024.07.006","url":null,"abstract":"<div><div>The quadricuspid aortic valve (QAV) is a rare congenital heart defect characterized by the presence of 4 cusps in the aortic valve structure. It is frequently associated with other congenital heart defects. Patients are usually asymptomatic, but when this condition is associated with functional disorders such as aortic regurgitation or stenosis, clinical manifestations are evident. The final diagnosis is made using different cardiac imaging techniques such as echocardiography, cardiac tomography, and nuclear magnetic resonance.</div><div>The treatment of this condition depends on the functionality of the aortic valve, and accordingly will be the indication for surgical treatment. The prognosis is generally favorable and depends on the functional compromise of the valve.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 53-58"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143171070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.rccl.2024.09.002
Álvaro Lorente Ros , Sonia Antoñana Ugalde , Álvaro Izquierdo Bajo , Luna Carrillo Alemán
Environmental pollution profoundly affects cardiovascular health. Traditionally, recommendations on cardiovascular disease (CVD) prevention focus on modifiable behavioral and metabolic risk factors, but environmental pollution is emerging as a critical factor, causing up to 20% of cardiovascular mortality.
This review explores the impact of environmental factors on cardiovascular health, examining the evidence on contaminants such as microplastics, atmospheric and acoustic pollution, and exposure to heavy metals. It evaluates their influence on the development of cardiovascular disease and their association with increased mortality, as well as their interaction with traditional risk factors. Addressing environmental pollution is not only crucial for CVD prevention, but also an ethical imperative. A holistic approach that considers both traditional and environmental risk factors is crucial for designing effective public health strategies and addressing the ethical dimension inherent in the protection of human health and the environment.
{"title":"Contaminación ambiental y salud cardiovascular: enfoque integral y nuevas evidencias","authors":"Álvaro Lorente Ros , Sonia Antoñana Ugalde , Álvaro Izquierdo Bajo , Luna Carrillo Alemán","doi":"10.1016/j.rccl.2024.09.002","DOIUrl":"10.1016/j.rccl.2024.09.002","url":null,"abstract":"<div><div>Environmental pollution profoundly affects cardiovascular health. Traditionally, recommendations on cardiovascular disease (CVD) prevention focus on modifiable behavioral and metabolic risk factors, but environmental pollution is emerging as a critical factor, causing up to 20% of cardiovascular mortality.</div><div>This review explores the impact of environmental factors on cardiovascular health, examining the evidence on contaminants such as microplastics, atmospheric and acoustic pollution, and exposure to heavy metals. It evaluates their influence on the development of cardiovascular disease and their association with increased mortality, as well as their interaction with traditional risk factors. Addressing environmental pollution is not only crucial for CVD prevention, but also an ethical imperative. A holistic approach that considers both traditional and environmental risk factors is crucial for designing effective public health strategies and addressing the ethical dimension inherent in the protection of human health and the environment.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 ","pages":"Pages 3-11"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143156640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.rccl.2024.10.001
Manuel Giráldez Suárez , Irene Martín de Miguel , Mercedes Rivas-Lasarte , María Álvarez Barredo
Pulmonary arterial hypertension (PAH) is a rare and serious pathology in which abnormal pulmonary vascular remodeling occurs causing increased pulmonary vascular resistance, pulmonary pressures and right ventricular afterload, leading to right heart failure due to right ventricular failure, which is the main cause of death. Advances in the understanding of the pathophysiological mechanisms of the disease have allowed the development of new molecular compounds aimed at partially reversing the alterations in the pulmonary vasculature, providing additional mechanisms of action and therapeutic targets to the classic pulmonary vasodilator drugs. This work covers a review of the pathophysiological mechanisms, the diagnostic process of PAH, considering how to integrate the different clinical elements and diagnostic tests for an early and correct diagnosis, and presents the available and developing molecular compounds with an analysis of the potential role of the latter in current therapeutic algorithms.
{"title":"Abordaje de la hipertensión arterial pulmonar para el clínico: fisiopatología, diagnóstico y tratamiento","authors":"Manuel Giráldez Suárez , Irene Martín de Miguel , Mercedes Rivas-Lasarte , María Álvarez Barredo","doi":"10.1016/j.rccl.2024.10.001","DOIUrl":"10.1016/j.rccl.2024.10.001","url":null,"abstract":"<div><div>Pulmonary arterial hypertension (PAH) is a rare and serious pathology in which abnormal pulmonary vascular remodeling occurs causing increased pulmonary vascular resistance, pulmonary pressures and right ventricular afterload, leading to right heart failure due to right ventricular failure, which is the main cause of death. Advances in the understanding of the pathophysiological mechanisms of the disease have allowed the development of new molecular compounds aimed at partially reversing the alterations in the pulmonary vasculature, providing additional mechanisms of action and therapeutic targets to the classic pulmonary vasodilator drugs. This work covers a review of the pathophysiological mechanisms, the diagnostic process of PAH, considering how to integrate the different clinical elements and diagnostic tests for an early and correct diagnosis, and presents the available and developing molecular compounds with an analysis of the potential role of the latter in current therapeutic algorithms.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 ","pages":"Pages 24-40"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143157101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.rccl.2024.09.003
Luis Carlos Maestre-Luque , Rafael González-Manzanares , Clara Fernández-Cordón , Felipe Díez-Delhoyo
The broad spectrum of patients with chronic coronary syndrome and the controversies in diagnosis and treatment pose a major challenge in clinical decision making. Concerning the diagnosis, the utility of myocardial viability study has been questioned by recent clinical trials. Regarding the therapeutic approach, in patients with simple coronary disease, percutaneous revascularization has proved its utility in anginal symptoms relieve, but the evidence regarding a prognostic benefit is contradictory. In complex coronary disease, coronary artery bypass grafting surgery has reported better results than percutaneous intervention. Besides, surgical revascularization has demonstrated a reduction in cardiovascular events over medical treatment in patients with ischemic left ventricular dysfunction. In this review we critically analyse the current evidence on viability study and myocardial revascularization in patients with chronic coronary syndrome.
{"title":"Controversias en la revascularización y el estudio de viabilidad miocárdica en el síndrome coronario crónico","authors":"Luis Carlos Maestre-Luque , Rafael González-Manzanares , Clara Fernández-Cordón , Felipe Díez-Delhoyo","doi":"10.1016/j.rccl.2024.09.003","DOIUrl":"10.1016/j.rccl.2024.09.003","url":null,"abstract":"<div><div>The broad spectrum of patients with chronic coronary syndrome and the controversies in diagnosis and treatment pose a major challenge in clinical decision making. Concerning the diagnosis, the utility of myocardial viability study has been questioned by recent clinical trials. Regarding the therapeutic approach, in patients with simple coronary disease, percutaneous revascularization has proved its utility in anginal symptoms relieve, but the evidence regarding a prognostic benefit is contradictory. In complex coronary disease, coronary artery bypass grafting surgery has reported better results than percutaneous intervention. Besides, surgical revascularization has demonstrated a reduction in cardiovascular events over medical treatment in patients with ischemic left ventricular dysfunction. In this review we critically analyse the current evidence on viability study and myocardial revascularization in patients with chronic coronary syndrome.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 ","pages":"Pages 12-23"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143157102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.rccl.2024.10.008
Eva Moreno Monterde , Amadeo Wals Rodríguez , Olga Durán Bobin , Ana Laffond
The Congress of Young Cardiologists, known as CardioMIR, is an annual cardiovascular update meeting where new topics in the field of cardiology are reviewed. Its 5th edition was held on September 20-21, 2024, in Seville, bringing together more than 400 young cardiologists, both residents and specialists, to share the latest updates on cardiology and cardiovascular health in a dynamic format, both in-person and online. The purpose of this article is to summarize the main topics discussed during the 5th edition of CardioMIR.
{"title":"V CardioMIR: el Congreso de los Jóvenes Cardiólogos","authors":"Eva Moreno Monterde , Amadeo Wals Rodríguez , Olga Durán Bobin , Ana Laffond","doi":"10.1016/j.rccl.2024.10.008","DOIUrl":"10.1016/j.rccl.2024.10.008","url":null,"abstract":"<div><div>The Congress of Young Cardiologists, known as CardioMIR, is an annual cardiovascular update meeting where new topics in the field of cardiology are reviewed. Its 5th edition was held on September 20-21, 2024, in Seville, bringing together more than 400 young cardiologists, both residents and specialists, to share the latest updates on cardiology and cardiovascular health in a dynamic format, both in-person and online. The purpose of this article is to summarize the main topics discussed during the 5th edition of CardioMIR.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 ","pages":"Pages 41-50"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143157103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01DOI: 10.1016/j.rccl.2024.03.002
Introduction and objectives
A lower accuracy of functional tests for the diagnosis of significant coronary disease in patients with left bundle branch block (LBBB) has been described, due to a greater number of false positives. The aim of this study was to evaluate whether an anatomic test such as computerized tomography coronary angiogram (CTCA) outperforms SPECT myocardial perfusion imaging (SPECT-MPI) or dobutamine stress echocardiography (DSE) in the diagnosis of significant coronary artery disease in patients with LBBB and right ventricular pacing.
Methods
Observational study of 149 patients with LBBB and right ventricular pacing referred to SPECT-MPI, DSE or CTCA at three centers. Diagnostic performance (predictive accuracy, sensitivity, specificity, positive and negative predictive value) was evaluated using coronary angiography as the benchmark.
Results
The study included 77 patients who underwent SPECT-MPI, 39 who performed DSE and 33 who performed CTCA. The prevalence of obstructive coronary disease was similar in the three cohorts, with a higher rate of abnormal results on SPECT-MPI (84% vs 64% vs 61%; P = .009). Predicted accuracy was significantly lower in the SPECT-MPI group (39% vs 64% vs 67%; P = .006). DSE and CTCA showed a similar rate of abnormal results, as well as similar predictive accuracy (64% vs 67%; P > .999).
Conclusions
In patients with LBBB and right ventricular pacing, DSE and CTCA had similar accuracy and performed better than SPECT-MPI for the diagnosis of significant coronary artery disease.
导言和目的有研究表明，功能检查诊断左束支传导阻滞（LBBB）患者明显冠状动脉疾病的准确性较低，原因是假阳性的数量较多。本研究旨在评估计算机断层扫描冠状动脉造影（CTCA）等解剖学检查在诊断左束支传导阻滞和右室起搏患者的重大冠状动脉疾病方面是否优于 SPECT 心肌灌注成像（SPECT-MPI）或多巴酚丁胺负荷超声心动图（DSE）。方法对三个中心转诊至 SPECT-MPI、DSE 或 CTCA 的 149 名左束支传导阻滞和右室起搏患者进行观察研究。以冠状动脉造影为基准，对诊断性能（预测准确性、敏感性、特异性、阳性预测值和阴性预测值）进行了评估。结果该研究包括 77 名接受 SPECT-MPI 的患者、39 名接受 DSE 的患者和 33 名接受 CTCA 的患者。三组患者中阻塞性冠状动脉疾病的发病率相似，但 SPECT-MPI 结果异常率较高（84% vs 64% vs 61%; P = .009）。SPECT-MPI 组的预测准确率明显较低（39% vs 64% vs 67%; P = .006）。结论在 LBBB 和右心室起搏患者中，DSE 和 CTCA 的准确性相似，在诊断重大冠状动脉疾病方面的表现优于 SPECT-MPI。
{"title":"Diagnostic accuracy of anatomic vs functional tests for coronary artery disease in patients with left bundle branch block and right ventricular pacing","authors":"","doi":"10.1016/j.rccl.2024.03.002","DOIUrl":"10.1016/j.rccl.2024.03.002","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>A lower accuracy of functional tests for the diagnosis of significant coronary disease in patients with left bundle branch block (LBBB) has been described, due to a greater number of false positives. The aim of this study was to evaluate whether an anatomic test such as computerized tomography coronary angiogram (CTCA) outperforms SPECT myocardial perfusion imaging (SPECT-MPI) or dobutamine stress echocardiography (DSE) in the diagnosis of significant coronary artery disease in patients with LBBB and right ventricular pacing.</div></div><div><h3>Methods</h3><div>Observational study of 149 patients with LBBB and right ventricular pacing referred to SPECT-MPI, DSE or CTCA at three centers. Diagnostic performance (predictive accuracy, sensitivity, specificity, positive and negative predictive value) was evaluated using coronary angiography as the benchmark.</div></div><div><h3>Results</h3><div>The study included 77 patients who underwent SPECT-MPI, 39 who performed DSE and 33 who performed CTCA. The prevalence of obstructive coronary disease was similar in the three cohorts, with a higher rate of abnormal results on SPECT-MPI (84% vs 64% vs 61%; <em>P</em> <!-->=<!--> <!-->.009). Predicted accuracy was significantly lower in the SPECT-MPI group (39% vs 64% vs 67%; <em>P</em> <!-->=<!--> <!-->.006). DSE and CTCA showed a similar rate of abnormal results, as well as similar predictive accuracy (64% vs 67%; <em>P</em> <!-->><!--> <!-->.999).</div></div><div><h3>Conclusions</h3><div>In patients with LBBB and right ventricular pacing, DSE and CTCA had similar accuracy and performed better than SPECT-MPI for the diagnosis of significant coronary artery disease.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 4","pages":"Pages 295-302"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140766134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号